MedTrace Logo

Feasibility of Remote Monitoring of Patients With Myasthenia Gravis

NCT07787247 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2026-08-26

No results posted yet for this study

Summary

Myasthenia gravis is an autoimmune neuromuscular disorder characterized by fluctuating weakness, which can worsen suddenly without a clear predictor. The hypothesis is that continuous monitoring of key aspects of patient physiology and activity coupled to rigorous telemedicine-performed examination has the potential to detect MG worsening which requires change in treatment with the benefit of avoiding need for hospitalization or emergent therapy. This study is to evaluate the reliability of the technology and patient compliance to the monitoring program

Conditions

  • Myasthenia Gravis (MG)

Sponsors & Collaborators

  • George Washington University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-19
Primary Completion
2028-10-31
Completion
2028-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07787247 on ClinicalTrials.gov